BioCentury | Mar 27, 2020
Emerging Company Profile

Redpin debuts chemogenetic platform for neurology, raises $15.5M

...procedure. The ion channels can then be activated as needed by the anti-smoking drug Chantix varenicline...
...choose the drug and make a receptor for it,” Hawkins told BioCentury. Hawkins noted that Chantix...
...chimeric ligand-gated ion channels Targets nAchR - Nicotinic acetylcholine receptor Elizabeth S. Eaton, Staff Writer Champix, Chantix, varenicline chemogenetics ion...
BioCentury | Oct 31, 2019
Financial News

Oyster Point, RAPT post gains after pricing IPOs at low end of range

...Jaffray are underwriters. The company expects to submit an NDA to FDA in 2H20 for varenicline...
BioCentury | Oct 4, 2019
Financial News

Oct. 4 Financial Quick Takes: Innovent raises $300M in Hong Kong's first biotech follow-on; plus Oyster Point, Heron, Molecular Assemblies and Geneoscopy

...company expects to submit an NDA to FDA in 2H20 for its dry eye candidate varenicline...
BioCentury | Mar 1, 2019
Financial News

Oyster Point raises $93M series B to bring dry eye nasal spray to FDA

...and commercialize the therapy. OC-01 has the same active ingredient as smoking cessation drug Chantix varenicline...
BioCentury | Feb 26, 2019
Financial News

Oyster Point raises $93M series B to bring dry eye nasal spray to FDA

...and commercialize the therapy. OC-01 has the same active ingredient as smoking cessation drug Chantix varenicline...
BioCentury | Jan 8, 2019
Distillery Therapeutics

Neurology

...nAChR α 4 β 2 agonist Tabex cystisine for smoking cessation. Pfizer Inc. markets Chantix varenicline...
BioCentury | Nov 19, 2018
Regulation

FDA to apply light touch to biopharma apps

...Log app that helps patients track symptoms. Pfizer Inc., manufacturer of smoking cessation drug Chantix varenicline...
BioCentury | Jul 9, 2018
Company News

Trump blasts Pfizer for price hikes, threatens to respond

...glaucoma drug Xalatan latanoprost each saw a 9% increase in WAC; smoking cessation aid Chantix varenicline's...
...that will have large effects on drug prices in the short term. Jaime De Leon Champix, Chantix, varenicline Lyrica...
BioCentury | Sep 5, 2016
Strategy

Back to School 2016: Haste, not waste

As researchers in industry and academia rapidly unravel molecular disease mechanisms and drug developers become more adept at intervening in disease pathways with drugs targeted to specific populations, the current clinical development paradigm cannot keep...
BioCentury | Aug 8, 2016
Regulation

Better Modeling Through PDUFA

...prevent and treat secondary hyperparathyroidism associated with stage 5 chronic kidney disease (CKD) and Chantix varenicline...
...based simulations demonstrated the best dosing regimen. Similarly, he said lower doses were approved for Chantix...
...additional clinical trials. Data from both modeling exercises are on the labels for Zemplar and Chantix...
Items per page:
1 - 10 of 72